Sales & Marketing News | pharmaphorum

News

UK extends COVID-19 vaccine supply deal with Valneva

The UK government has signed a €1.4 billion ($1.66 billion) order for up to 190 million doses of a coronavirus vaccine in development at French company Valneva.

News

A healthy discussion on funding tomorrow’s treatments

Despite biosims, ulcerative colitis drugs still cost too muc...

None of the immune-modulating drugs approved to treat ulcerative colitis – even biosimilars – are priced low enough to be cost-effective, says the Institute for Clinical and Economic Review

News

Roche hits back at Novartis with new data for MS drug Ocrevu...

Roche has hit back at Novartis’ newly-approved multiple sclerosis drug Kesimpta, with new data from its already-marketed blockbuster Ocrevus.

News

Ex-Allergan CEO Saunders pops up again in ‘blank cheque’ com...

Brent Saunders has been out of the limelight for a few months since departing Allerg

News

GSK steals march on AZ as FDA approves Trelegy in asthma

The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults, adding to its existing use in chronic obstructive pulmonary disease (COPD), stealing a march on rivals A

News